ReviewCancer drug resistance (Alhambra, Calif.)2020

Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions.

Viktorija Juric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.